RxDoctor Payments Data

Dina Miller, MD

Physical Medicine & Rehabilitation · Bayside, NYNPI 1316975725

Payments from drug & device makers

$1,864in general payments, 2019–2025

Across 136 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$566
  • Collegium Pharmaceutical, Inc.$259
  • Actelion Pharmaceuticals US, Inc.$241
  • Amgen$149
  • Scilex Pharmaceuticals Inc.$144
  • Pfizer$110
  • plus $395 from 12 others

What the payments were for

  • Food & beverage$1,864100%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,864 in reported general payments places this provider in the 80th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$196,948
Medicare patients
98
Services billed
8,332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl59$49,256
ZtlidoLidocaine25$29,722
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl103$6,717
Lidocaine50$5,606
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen127$2,956
Pregabalin113$2,387
Trazodone Hcl16$2,117
Mirtazapine21$2,045
Sumatriptan Succinate45$1,145
Tramadol Hcl137$1,122
Diclofenac Sodium64$1,053
Escitalopram Oxalate31$843
Tramadol Hcl ErTramadol Hcl18$842
Methadone Hcl46$775
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine25$726

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er$259$49,25659 claims
Scilex Pharmaceuticals Inc.Ztlido$144$29,72225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in Bayside

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →